Although various mechanisms of drug resistance have been proposed [32], the most commonly described mechanism is the compensatory mechanism, in which a non-VEGF angiogenic factor is produced as an alternative to drive tumor angiogenesis [33]. This evidence concerns the gene VEGFA and neoplasm.